・Bayer announced that it is halting a late-stage trial for asundexian, a high-profile candidate for cardiovascular disease.
・Bristol Myers Squibb and Johnson & Johnson are co-developing a therapy that belongs to the same class as asundexian.
・The market took the news as a bad omen for BMS and J&J's rival therapy.
下がってる理由これですね。。
・Bayer announced that it is halting a late-stage trial for asundexian, a high-profile candidate for cardiovascular disease.
・Bristol Myers Squibb and Johnson & Johnson are co-developing a therapy that belongs to the same class as asundexian.
・The market took the news as a bad omen for BMS and J&J's rival therapy.